Valion Bio, Inc.
For the period ended Jun 30, 2025. Filed Jun 2, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 30, 2025 · Filed Jun 2, 2025
Use the contents to explore the available documents and sections.
Contents
Effective Date
The Plan Amendment will be effective as of June 30, 2025, subject to stockholder approval at the Annual Meeting.
The affirmative (“FOR”) vote of a majority of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote on the subject matter is required to approve the Plan Amendment. Abstentions, if any, will be treated as shares that are present and entitled to vote on this proposal, and will therefore be treated as a vote “AGAINST” this Proposal 2. This Proposal 2 is a non-routine proposal on which a broker or other nominee does not have discretionary authority to vote. Broker non-votes will not affect the outcome of the vote on this proposal.
A VOTE FOR THE APPROVAL OF THE PLAN AMENDMENT
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.